Martin Luutar Kiing Jr: Seenaa US keessatti nama fakkeenya ta'e garuu ammallee sirnaan hin hubatamne
Martin Luutar Kiing seena siyaasaa US keessatti nama mallattoo falmaa mirga dhala namaa ta'edha, garuu seenaansaa qixa sirrii ...
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...
A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA - a genetically validated target that provides a new approach for healthy, sustainable weight loss (fat loss with muscle preservation) ...
LONDON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- e-therapeutics plc, a company integrating computational power and biological data to discover life-transforming RNAi medicines, announced today that it will ...
Registration Link for Presentation and live Q&A to take place, Tuesday February 4, 2025 at 2:00 pm EST Marlborough, Massachusetts--(Newsfile Corp. - February 3, 2025) - Phio Pharmaceuticals Corp.
A research team has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.
Wave Life Sciences (WVE) announced clinical trial application, CTA, approval and initiation of the Phase 1 INLIGHT clinical trial of WVE-007 in ...
Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) has received an average recommendation of “Buy” from the six ratings ...
4d
GlobalData on MSNAlys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trialAlys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results